Human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: Issues in interim monitoring and early stopping

R. Zackin, I. Marschner, J. Andersen, M. K. Cowles, V. De Gruttola, S. Hammer, M. Fischl, D. Cotton

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'Human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: Issues in interim monitoring and early stopping'. Together they form a unique fingerprint.

Medicine & Life Sciences